Skip to main content

Moderna backtracks to open COVID vaccine trial to those with HIV

By Bloomberg  
   August 07, 2020

After pressure from advocates in recent weeks, Moderna Inc. will now allow individuals living with HIV to be part of a late-stage clinical trial of its Covid-19 vaccine candidate. Moderna had previously said it would exclude people with HIV from the trial.

Full story


Get the latest on healthcare leadership in your inbox.